Skip to main content
. 2018 Sep 30;2018:3953579. doi: 10.1155/2018/3953579

Table 1.

Baseline characteristics of patients.

Age/sex Comorbid conditions Decitabine EF 1a Biomarker Testb EF 2c EF Δd
De et al. [6] (2012) 75 yrs/M DM type II, DVT 2 cycles 35% BNP: 259 Coronary angiogram 50% (after 7 days) Yes
Our patient 71 yrs/F HTN, Hep B, hypothyroidism 10 cycles 28% Pro-BNP: 517 Nuclear stress test 28% (after 4 weeks) but with improvement in strain No

aBaseline left ventricular ejection fraction. bTest to rule out coronary artery disease. cRepeat left ventricular ejection fraction. dReversibility of ejection fraction. Note: both patients received decitabine as part of treatment for acute myeloid leukemia. Abbreviations: BNP: brain natriuretic peptide; DM: diabetes mellitus; DVT: deep vein thrombosis; EF: ejection fraction; HTN: hypertension; Hep B: hepatitis B; BNP units: pg/ml.